Dr Reddys Laboratories (RDY) EBITDA Margin (QoQ) (2009 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 293.00 |
| Mar 31, 2026 | -1,455.00 |
| Dec 31, 2025 | -357.00 |
| Sep 30, 2025 | -56.00 |
| Jun 30, 2025 | -30.00 |
| Mar 31, 2025 | -165.00 |
| Dec 31, 2024 | 50.00 |
| Sep 30, 2024 | -147.00 |
| Jun 30, 2024 | 224.00 |
| Mar 31, 2024 | -281.00 |
| Dec 31, 2023 | -204.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -17.00 |
| Mar 31, 2023 | 645.00 |
| Dec 31, 2022 | -458.00 |
| Sep 30, 2022 | 86.00 |
| Jun 30, 2022 | 2,062.00 |
| Mar 31, 2022 | -767.00 |
| Dec 31, 2021 | -694.00 |
| Sep 30, 2021 | -357.00 |